Paid Clinical Trials in California

California has 6,384 paid clinical trials enrolling now across cities including Los Angeles, San Francisco and San Diego. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in California include Stanford Medicine, UCLA Health and UCSF, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 25, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

5,286 clinical trials

↓ Download CSV

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

for Head and Neck Squamous Cell Carcinoma (HNSCC)

Sites in Los Angeles +3 more locations

Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT05985655·Phase 1, Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

Effects of Variations in Caffeinated Beverages on Well-being

for Healthy

1 location in San Francisco

Sponsor: GUAYAKI SUSTAINABLE RAINFOREST PRODUCTS, INC.

Sex: All·Age: 18 - 55·Accepts healthy volunteers

Code: NCT07404254·Recruiting·Listed Feb 2026

Apply to this trial

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

for Locally Advanced Pancreatic Adenocarcinoma

Sites in Stanford +6 more locations

Sponsor: EXACT Therapeutics AS

Sex: All·Age: 18+

Code: NCT06850623·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)

for Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome

Sites in San Diego +7 more locations

Sponsor: Ionis Pharmaceuticals, Inc.

Sex: Male·Age: 2 - 65

Code: NCT06430385·Phase 1, Phase 2·Recruiting·Listed May 2024

Apply to this trial

International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder

for Autism Spectrum Disorder

Sites in Sherman Oaks +4 more locations

Sponsor: Stalicla SA

Sex: All·Age: 12 - 65

Code: NCT05590715·Recruiting·Listed Oct 2022

Apply to this trial

Study of CTO1681 for the Prevention and Treatment of CRS in DLBCL Patients Receiving CAR T-Cell Therapy

for Cytokine Release Syndrome

Sites in Orange +5 more locations

Sponsor: CytoAgents, Inc.

Sex: All·Age: 18+

Code: NCT05905328·Phase 1, Phase 2·Recruiting·Listed Jun 2023

Apply to this trial

SLV-324 Treatment of Metastatic Solid Tumors

for Metastatic Solid Tumors

Sites in Newport Beach +6 more locations

Sponsor: Solve Therapeutics

Sex: All·Age: 18+

Code: NCT07108114·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

A Study of AAV9 Gene Therapy in Participants With Canavan Disease (CANaspire Clinical Trial)

for Canavan Disease

Sites in Oakland +2 more locations

Sponsor: Aspa Therapeutics

Sex: All·Age: Up to 30 Months

Code: NCT04998396·Phase 1, Phase 2·Recruiting·Listed Aug 2021

Apply to this trial

Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study

for Deep Vein Thrombosis

1 location in Los Angeles

Sponsor: Cook Research Incorporated

Sex: All·Age: 18+

Code: NCT05881798·Recruiting·Listed May 2023

Apply to this trial

The HYALEX Pivotal Study

for Damaged Chondral or Osteochondral Area

Sites in La Mesa +3 more locations

Sponsor: Hyalex Orthopaedics, Inc.

Sex: All·Age: 22 - 70

Code: NCT06368700·Recruiting·Listed Apr 2024

Apply to this trial

TATE and Pembrolizumab (MK3475) in mCRC and NSCLC

for Colorectal Cancer

1 location in Orange

Sponsor: Teclison Ltd.

Sex: All·Age: 18+

Code: NCT04701476·Phase 2·Recruiting·Listed Jan 2021

Apply to this trial

Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women

for Overactive Bladder

Sites in Palo Alto +8 more locations

Sponsor: InMode MD Ltd.

Sex: Female·Age: 22 - 80

Code: NCT07209397·Recruiting·Listed Oct 2025

Apply to this trial

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

for B-cell Acute Lymphoblastic Leukemia

Sites in Los Angeles, Duarte +7 more locations

Sponsor: Vironexis Biotherapeutics Inc.

Sex: All·Age: 13 - 90

Code: NCT06533579·Phase 1, Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

for Parkinson Disease

Sites in Palo Alto, Irvine +3 more locations

Sponsor: Supernus Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT07219927·Recruiting·Listed Oct 2025

Apply to this trial

CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)

for AML

Sites in Sacramento +3 more locations

Sponsor: CERo Therapeutics Holdings, Inc.

Sex: All·Age: 18 - 85

Code: NCT06834282·Phase 1·Recruiting·Listed Feb 2025

Apply to this trial

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

for Schizophrenia

Sites in Anaheim +3 more locations

Sponsor: BioXcel Therapeutics Inc

Sex: All·Age: 10 - 17

Code: NCT05025605·Phase 1·Recruiting·Listed Aug 2021

Apply to this trial

Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome

for Cushing Syndrome

Sites in San Francisco +3 more locations

Sponsor: RECORDATI GROUP

Sex: All·Age: 2 - 17

Code: NCT03708900·Phase 2·Recruiting·Listed Oct 2018

Apply to this trial

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

for Prostate Cancer (Adenocarcinoma)

Sites in La Jolla +7 more locations

Sponsor: Acerand Therapeutics (Hong Kong) Limited

Sex: Male·Age: 18+

Code: NCT06801236·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

Enhancing Heart Allograft Function With the OCS Heart System Trial

for Heart Transplant

Sites in San Francisco +7 more locations

Sponsor: TransMedics

Sex: All·Age: 18+

Code: NCT07145515·Recruiting·Listed Aug 2025

Apply to this trial

A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)

for Dry Age-related Macular Degeneration

Sites in Los Angeles, Beverly Hills +3 more locations

Sponsor: Regenerative Patch Technologies, LLC

Sex: All·Age: 55 - 90

Code: NCT06557460·Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients

for Infection

Sites in San Francisco +5 more locations

Sponsor: Karius, Inc.

Sex: All·Age: 18+

Code: NCT07110636·Recruiting·Listed Aug 2025

Apply to this trial

Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC

for Diabetic Foot Ulcer

Sites in Vista +1 more location

Sponsor: Surgenex

Sex: All·Age: 18+

Code: NCT06515093·Recruiting·Listed Jul 2024

Apply to this trial

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars

for Corneal Scar

Sites in Loma Linda +6 more locations

Sponsor: Claris Biotherapeutics, Inc.

Sex: All·Age: 18 - 80

Code: NCT06257355·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis

for Neurotrophic Keratitis

Sites in Irvine, Pasadena +7 more locations

Sponsor: Krystal Biotech, Inc.

Sex: All·Age: 18+

Code: NCT06999733·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis

for Low-grade Upper Tract Urothelial Carcinoma

Drug: Nadofaragene Firadenovec

Sites in Santa Monica +8 more locations

Sponsor: Ferring Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06668493·Phase 1, Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

Impact of Reducose® on Glycemic Response and Menopausal Symptoms in Perimenopausal Women (CALM-R)

for Glycemic Response

1 location in Los Angeles

Sponsor: Phynova Group Ltd

Sex: Female·Age: 40 - 60·Accepts healthy volunteers

Code: NCT07333885·Recruiting·Listed Jan 2026

Apply to this trial

A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas

for Colorectal Carcinoma

Sites in Los Angeles +2 more locations

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT06882746·Phase 1·Recruiting·Listed Mar 2025

Apply to this trial

A Study of CTD402 in T-ALL/LBL Patients

for Acute Lymphocytic Leukemia Refractory

Sites in Palo Alto +7 more locations

Sponsor: Imviva Bio

Sex: All·Age: 12+

Code: NCT07070219·Phase 1, Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

for Acute Myeloid Leukemia

Sites in Duarte +6 more locations

Sponsor: Debiopharm International SA

Sex: All·Age: 18+

Code: NCT06969430·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

for Prostate Cancer Castration-resistant Prostate Cancer

Sites in San Francisco +6 more locations

Sponsor: MBrace Therapeutics

Sex: All·Age: 18+

Code: NCT07145255·Phase 1, Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

Prospective Multi-Center Trial for FemBloc Permanent Birth Control

for Contraception

Sites in Palo Alto, Sacramento +6 more locations

Sponsor: Femasys Inc.

Sex: Female·Age: 21 - 50·Accepts healthy volunteers

Code: NCT05977751·Recruiting·Listed Aug 2023

Apply to this trial

EDX110 Randomized Control Trial for Treatment of DFUs

for Wound Heal

Sites in Santa Ana, Vista +2 more locations

Sponsor: ConvaTec Inc.

Sex: All·Age: 18 - 90

Code: NCT07209358·Recruiting·Listed Oct 2025

Apply to this trial

CardioMEMS HF System Coverage With Evidence Development Study

for Heart Failure

1 location in Pleasanton

Sponsor: Abbott Medical Devices

Sex: All·Age: 18+

Code: NCT06779552·Recruiting·Listed Jan 2025

Apply to this trial

Study of WAL0921 in Patients With Glomerular Kidney Diseases

for Diabetic Nephropathies

Sites in Los Angeles +8 more locations

Sponsor: Walden Biosciences

Sex: All·Age: 18 - 75

Code: NCT06466135·Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

for Triple Negative Breast Cancer

Sites in Los Angeles +8 more locations

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT06926920·Phase 1, Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

for Lymphoma

Sites in Duarte +3 more locations

Sponsor: VIVUS LLC

Sex: All·Age: 18+

Code: NCT06915246·Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

for Cancer

Sites in Los Angeles +5 more locations

Sponsor: Angiex, Inc.

Sex: All·Age: 18+

Code: NCT06440005·Phase 1·Recruiting·Listed Jun 2024

Apply to this trial

A Study to Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before or During Pregnancy And About The Health of Their Babies

for Muscular Atrophy, Spinal

Sites in Palo Alto +2 more locations

Sponsor: Biogen

Sex: Female·Age: 18 - 54

Code: NCT05789758·Recruiting·Listed Mar 2023

Apply to this trial

SNV4818 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Los Angeles +4 more locations

Sponsor: Pikavation Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06736704·Phase 1, Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

A First-in-Human Single and Multiple Ascending Dose Study of MT-201

for Healthy Volunteer

1 location in San Diego

Sponsor: Mirador Therapeutics, Inc.

Sex: All·Age: 19 - 55·Accepts healthy volunteers

Code: NCT07219368·Phase 1·Recruiting·Listed Oct 2025

Apply to this trial